Programme 201613 - 14 July, 2016–Rutgers University, Newark, NJ, USA

TTS NORTH AMERICA Rutgers University, Newark, 13 - 14 July, 2016 Day 1

08:30 Registration & Coffee

09:00 Official Opening and Welcoming Introduction to the 9th Annual TTS North America

  – TTS Global Initiative

– Debbie Hart, President & CEO, BioNJ

– Christopher J. Molloy, Senior Vice President for Research, Rutgers, The State University of New Jersey

09:15 Keynote; What industry expects from academia and TTOs

– Juan Carlos Lopez, Global Head of Academic Relations & Alliances, Roche

10:00 Translational research as a key driver of innovation in biotech and healthcare at universities of all sizes.

– June Lee, Professor of Medicine, Director of Early Translational Research at the Clinical and

Translational Science Institute (CTSI), UCSF, San Francisco – David Kimball, Associate VP Office of Translational Science, Rutgers University, NJ – Nora Yang, Director of Portfolio Management & Program Operations, National Center for Advancing

Translational Sciences (NCATS) – Nadim Shohdy, Director, NYU Office of Therapeutics Alliances

11:00 Coffee & Networking Breakout

11:30 Industry Academia collaboration in the context of greater pharma engagement; the benefits to institutions and the increasing standard of expectations.

– Ofra Weinberger, Director of Licensing, Columbia Technology Ventures – Vincent Smeraglia, Executive Director, Office of Research Commercialization, Rutgers University, NJ – Judith Sheft, Associate Vice President Technology & Enterprise Development - New Jersey Innovation

Institute @ NJIT – Peter Tolias, Prof. & Interim Director, Dept. of Biomedical Engineering, Chemistry & Biological

Sciences, Director, Center for Healthcare Innovation, Stevens Institute of Technology

12:30 Networking Lunch.

13:30 Strategic business development; understanding the market, and working towards a partnership.

– John M. McGill, Senior Director, LRL Science and Technology Partnerships, Lilly Research Laboratories Eli Lilly & Company, Indianapolis

– Pavel Khrimian, Assoc. Director, Partnering & Strategy, Medimmune – Kamran Mammadov, Senior Director, The Medicines Company – Sally Shorthose, Partner, Bird & Bird, UK

TTS NORTH AMERICA Rutgers University, Newark, 13 - 14 July, 2016 Day 1 (CONTINUED)

14:30 Innovation in entrepreneurship: biotech business models. Founder/CEOs discuss lessons

learned along the way and their development strategies. – Elizabeth Posillico, Chief Executive Officer, Elusys, NJ – Patrick Tricoli, CEO, Nanobiotix Corporation, Boston, MA – Rob Sarisky, Chief Business Officer, Forma Therapeutics, Boston, MA – Lorenzo Pellegrini, President & CEO, Palladio Biosciences

16:00 Coffee & Networking Breakout.

16:30 Keynote: Financing bio sector spin-outs, start-ups and SMEs. – Jesse Treu, Partner, Domain Associates

17:00 Financing bio sector spin-outs, start-ups and SMEs.

– Jesse Treu, Partner, Domain Associates – Maarten deJong, Managing Director, Moelis & Company – Sara M. Nayeem, M.D., Partner, New Enterprise Associates – Cedric Bisson, Partner, Teralys Capital – Michael Wiley, Vice President, Foundation Venture Capital Group

18:00 End of Day One.

18:30 – 20:30

TTS North America Speakers & Partners Dinner Reception (by invitation) Hosted by NJII

TTS NORTH AMERICA Rutgers University, Newark, 13 - 14 July, 2016 Day 2 08:30 Registration & Coffee

09:00

Day 2 Kick Off

09:15 Keynote: Building an innovation ecosystem – Donald H. Sebastian, Ph.D., President & CEO, NJ Innovation Institute

10:00

IP & Patent Law: What the hell is happening now? And what does it mean for your company’s business model or your institution’s IP portfolio? – Kevin Noonan, Partner MBHP LLP, Editor & Co-Founder, Patent Docs

11:00 Coffee & Networking Breakout.

11:30

InnovationBOX – Innovation & Partnering: Short presentations followed by a panel discussion – Pavel Khrimian, Assoc. Director, Partnering & Strategy, Medimmune – M. Johnston Erwin, Vice President Strategy & Operations & Corporate Business Development, Eli Lilly

& Company – Brad Calvin, President, AsedaSciences Inc.

12:30 Closing Remarks & Discussion

– Tom Richardson, Vice President, Strategic Initiatives, BioNJ – Donald H. Sebastian, Ph.D., President & CEO, NJ Innovation Institute

12:45 Close of TTS North America & Networking Lunch Reception.